The Patent Finder

Biometrix Technology Inc.

6 patents currently held · Updated Nov 22, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

2
Ending by 2030
Dec 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 6, 2026
    The maintenance fee for Benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent comprising the same (US 11,667,661) comes due Dec 6, 2026. Unpaid by Jun 7, 2027, it lapses early.
  • 1 fee due Apr 22, 2027
    The maintenance fee for Method of designing DNA probe chip for room temperature hybridization and the DNA probe chip (US 10,450,600) comes due Apr 22, 2027. Unpaid by Oct 22, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 6 of 6

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,013,188Iminecalixarene derivatives and aminocalixarene derivatives, method of preparation thereof, and self-assembled monolayer prepared by the method, fixing method of oligo-DNA by using the self-assembled monolayer, and oligo-DNA chip prepared by the method
In force
 · USPTO record
In forceUSPTO record
US 10,450,600Method of designing DNA probe chip for room temperature hybridization and the DNA probe chip
In force
 · USPTO record
In forceUSPTO record
US 8,288,443Modified glass fiber with monolayer of aminocalixarene derivatives and iminecalixarene derivatives
In force
 · USPTO record
In forceUSPTO record
US 11,667,661Benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent comprising the same
In force
 · USPTO record
In forceUSPTO record
US 11,998,530Micelle comprising benzimidazole-carbohydrate conjugate compound, preparation method thereof and use thereof as anticancer agent or antiviral agent comprising the same
In force
 · USPTO record
In forceUSPTO record
US 12,043,644Benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent or anti-virus agent comprising the same
In force
 · USPTO record
In forceUSPTO record
Also on record, not counted in the 6: 1 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 no status recorded

Showing 1 to 3 of 3, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. No title is shown: the bulk publication record carries none for these applications, and this site holds no USPTO file history for them.

ApplicationFiledStatus
18/370,241Sep 19, 2023No status recorded
17/448,662Sep 23, 2021No status recorded
16/982,307Nov 13, 2019No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited